On the stock market since 2012, it operates in the world of health and science. It has 5,353 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
No real growth (-1% a year).
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades below its recent peak — about 14% off the top. A pullback, not a collapse.
It pays out $0.20 per share each year — regular cash for whoever holds the stock.
A loss of $0 against $16.3B in annual sales. And on top of that, sales fell from the year before.
The price action doesn’t yet back an upward turn. Council score: 0/10.
The sales tempo runs behind the sector. Council score: 2/10.
On our five-subject report card, HLUYY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: HLUYY has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.